Texas Oncology, Aetna Collaborate to Improve Patient Care Through Clinical Pathways
Texas Oncology and Aetna partnered to provide a practice-based program that reduced costs while maintaining adherence to treatment pathways and patient satisfaction in Medicare patients.
ASCO Releases Review of Prominent Commercial Clinical Pathway Vendors
The American Society of Clinical Oncology Task Force assessed 6 national pathway vendors to compare their products against the ASCO Criteria for High-Quality Clinical Pathways.
Real-World Outcomes of Patients With NSCLC Treated With PD-1 Inhibitors After Approval
Certain subgroups of patients with NSCLC are underrepresented in clinical trials for newly approved PD-1 inhibitors and are needed to inform real-world treatment decisions.